NYSE:VAPO
Vapotherm Inc. Stock News
$0.757
-0.0734 (-8.83%)
At Close: May 31, 2024
Vapotherm Reports First Quarter 2024 Financial Results
04:10pm, Thursday, 09'th May 2024
EXETER, N.H. , May 9, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced first quarter 2024 financial results and related highlights.
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
08:30am, Wednesday, 20'th Mar 2024
Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and device management goals for HVT® 2.0 and future H
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
07:36am, Friday, 15'th Mar 2024
EXETER, N.H. , March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming ME
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort
06:45am, Wednesday, 06'th Mar 2024
EXETER, N.H. , March 6, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced that David Yamane, MD was awarded the Star Research Award by the Society for
Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
06:45am, Thursday, 29'th Feb 2024
EXETER, N.H. , Feb. 29, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology company specializing in the development and commercialization of
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
04:10pm, Thursday, 22'nd Feb 2024
EXETER, N.H. , Feb. 22, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced fourth quarter and fiscal year 2023 financial results and related highlights
Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX
06:27pm, Thursday, 14'th Dec 2023
EXETER, N.H. , Dec. 14, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced it has received notice that the New York Stock Exchange ("NYSE") has determine
NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)
04:39pm, Thursday, 14'th Dec 2023
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common st
EXETER, N.H. , Dec. 11, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced its intention to voluntarily delist its common stock from The New York Stock E
Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month
04:54pm, Tuesday, 28'th Nov 2023
EXETER, N.H. , Nov. 28, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high veloc
Vapotherm, Inc. (VAPO) Q3 2023 Earnings Call Transcript
11:02pm, Wednesday, 08'th Nov 2023
Vapotherm, Inc. (NYSE:VAPO ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Dorota Mckay - VP and CAO Joe Army - President and CEO John Landry - SVP and CFO Conferen
Vapotherm Reports Third Quarter 2023 Financial Results
04:10pm, Wednesday, 08'th Nov 2023
EXETER, N.H. , Nov. 8, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), today announced third quarter 2023 financial results and related highlights.
3 Stocks Set to Rocket When the Bears Get Short-Squeezed
02:34pm, Thursday, 02'nd Nov 2023
Federal Reserve officials kept current interest rate levels unchanged on Wednesday. Investors and economists will be diligently scrutinizing any hints and clues offered during this meeting, specifical
Vapotherm To Report Third Quarter 2023 Financial Results
06:45am, Wednesday, 01'st Nov 2023
EXETER, N.H. , Nov. 1, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), today announced that it will release financial results for the third quarter of 2023 after the
Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas
06:45am, Wednesday, 04'th Oct 2023
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® p
